Xiwen Bi

1.2k total citations
46 papers, 725 citations indexed

About

Xiwen Bi is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Xiwen Bi has authored 46 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Oncology, 18 papers in Cancer Research and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Xiwen Bi's work include Breast Cancer Treatment Studies (12 papers), Lymphoma Diagnosis and Treatment (12 papers) and Cancer Treatment and Pharmacology (11 papers). Xiwen Bi is often cited by papers focused on Breast Cancer Treatment Studies (12 papers), Lymphoma Diagnosis and Treatment (12 papers) and Cancer Treatment and Pharmacology (11 papers). Xiwen Bi collaborates with scholars based in China, Japan and South Korea. Xiwen Bi's co-authors include Peng Sun, Yi Xia, Panpan Liu, Zhiming Li, Man Nie, Yu Wang, Wenqi Jiang, Hang Yang, Linbin Yang and Hang Yang and has published in prestigious journals such as Journal of Clinical Oncology, Blood and PLoS ONE.

In The Last Decade

Xiwen Bi

45 papers receiving 722 citations

Peers

Xiwen Bi
Jeffrey Schriber United States
Monika Csóka Hungary
Daniel Martı́nez Spain
Sunil Babu United States
Fengchun Zhang China
Soo Kee Min South Korea
Raju Vaddepally United States
Sang Eun Yoon South Korea
Sanghui Park South Korea
Stephan Schwarz Germany
Jeffrey Schriber United States
Xiwen Bi
Citations per year, relative to Xiwen Bi Xiwen Bi (= 1×) peers Jeffrey Schriber

Countries citing papers authored by Xiwen Bi

Since Specialization
Citations

This map shows the geographic impact of Xiwen Bi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiwen Bi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiwen Bi more than expected).

Fields of papers citing papers by Xiwen Bi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiwen Bi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiwen Bi. The network helps show where Xiwen Bi may publish in the future.

Co-authorship network of co-authors of Xiwen Bi

This figure shows the co-authorship network connecting the top 25 collaborators of Xiwen Bi. A scholar is included among the top collaborators of Xiwen Bi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiwen Bi. Xiwen Bi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Xu, Fei, Yongkui Lu, Caiwen Du, et al.. (2024). Pyrotinib and trastuzumab plus palbociclib and fulvestrant in HR+/HER2+ breast cancer patients with brain metastasis. npj Breast Cancer. 10(1). 45–45. 3 indexed citations
3.
Jiang, Kuikui, Ruoxi Hong, Qianyi Lu, et al.. (2023). Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-Arm, Prospective Study. Cancer Research and Treatment. 56(2). 513–521. 2 indexed citations
4.
Duan, Fangfang, Chenge Song, Jiajia Huang, et al.. (2022). Systemic Therapy Combined with Locoregional Therapy Improved Survival in Oligometastatic Breast Cancer: A Single-Center Retrospective Cohort Study. Journal of Oncology. 2022. 1–10. 1 indexed citations
5.
Duan, Fangfang, Li Wang, Chang Jiang, et al.. (2022). The Iron-Inflammation Axis in Early-Stage Triple-Negative Breast Cancer. Frontiers in Cell and Developmental Biology. 10. 784179–784179. 2 indexed citations
6.
Hong, Ruoxi, Wen Xia, Liye Wang, et al.. (2021). Safety, tolerability, and pharmacokinetics of BAT8001 in patients with HER2‐positive breast cancer: An open‐label, dose‐escalation, phase I study. Cancer Communications. 41(2). 171–182. 23 indexed citations
7.
Hua, Xin, Fangfang Duan, Jiajia Huang, et al.. (2021). A Novel Prognostic Model Based on the Serum Iron Level for Patients With Early-Stage Triple-Negative Breast Cancer. Frontiers in Cell and Developmental Biology. 9. 777215–777215. 7 indexed citations
8.
Yuan, Jing, Fangfang Duan, Wenyu Zhai, et al.. (2021). An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Breast Cancer. International Journal of Women s Health. Volume 13. 1053–1064. 7 indexed citations
9.
10.
Wang, Xinyue, Jibin Li, Wei Shi, et al.. (2020). Efficacy of Moxifloxacin plus Treatment of Physician's Choice in Patients with Metastatic Breast Cancer. The Oncologist. 25(10). e1439–e1445. 5 indexed citations
11.
Song, Chenge, Jiajia Huang, Wen Xia, et al.. (2020). Prognostic significance of the Controlling Nutritional Status (CONUT) score in surgically treated breast cancer patients. Gland Surgery. 9(5). 1370–1379. 18 indexed citations
12.
Zhang, Xuewen, Xiwen Bi, Panpan Liu, et al.. (2020). Expression of PD-L1 on Monocytes Is a Novel Predictor of Prognosis in Natural Killer/T-Cell Lymphoma. Frontiers in Oncology. 10. 1360–1360. 14 indexed citations
13.
Nie, Man, Linbin Yang, Xiwen Bi, et al.. (2018). Neutrophil Extracellular Traps Induced by IL8 Promote Diffuse Large B-cell Lymphoma Progression via the TLR9 Signaling. Clinical Cancer Research. 25(6). 1867–1879. 206 indexed citations
14.
Liu, Panpan, Kefeng Wang, Jietian Jin, et al.. (2018). Role of radiation therapy in primary breast diffuse large B‐cell lymphoma in the Rituximab era: a SEER database analysis. Cancer Medicine. 7(5). 1845–1851. 12 indexed citations
15.
16.
Li, Qiwen, Wěi Li, Liang Wang, et al.. (2015). Consolidation Radiotherapy in Stage IE- IIE, Non-Bulky Primary Gastric Diffuse Large B-Cell Lymphoma with Post-Chemotherapy Complete Remission. PLoS ONE. 10(7). e0133469–e0133469. 9 indexed citations
17.
Wang, Yu, Wen-Qi Jiang, Hui-Lan Rao, et al.. (2015). Expression of BAFF-R, but not BAFF, is an independent prognostic factor in diffuse large B-cell lymphoma patients treated with R-CHOP. Annals of Hematology. 94(11). 1865–1873. 16 indexed citations
18.
Bi, Xiwen, et al.. (2014). Advances in lymphoma maintenance therapy with rituximab. Clinical Oncology and Cancer Research. 41(24). 1612–1615. 1 indexed citations
19.
Bi, Xiwen, Ye‐Xiong Li, Hui Fang, et al.. (2013). High-Dose and Extended-Field Intensity Modulated Radiation Therapy for Early-Stage NK/T-Cell Lymphoma of Waldeyer's Ring: Dosimetric Analysis and Clinical Outcome. International Journal of Radiation Oncology*Biology*Physics. 87(5). 1086–1093. 45 indexed citations
20.
Wang, Jianbiao, et al.. (2012). NAD Induces Astrocyte Calcium Flux and Cell Death by ART2 and P2X7 Pathway. American Journal Of Pathology. 181(3). 746–752. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey Schriber Breakdown of academic impact, for papers by Monika Csóka Breakdown of academic impact, for papers by Daniel Martı́nez Breakdown of academic impact, for papers by Sunil Babu Breakdown of academic impact, for papers by Fengchun Zhang Breakdown of academic impact, for papers by Soo Kee Min Breakdown of academic impact, for papers by Raju Vaddepally Breakdown of academic impact, for papers by Sang Eun Yoon Breakdown of academic impact, for papers by Sanghui Park Breakdown of academic impact, for papers by Stephan Schwarz
Rankless by CCL
2026